NeoGenomics

Yahoo Finance • 9 days ago

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story

Yahoo Finance • 12 days ago

NEO Battery Closes Upsized Non-Brokered Private Placement Offering of $5.5 Million

TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, ro... Full story

Yahoo Finance • 17 days ago

Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO)

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Initial volatility in April stemmed from inc... Full story

Yahoo Finance • 19 days ago

NEO Battery Enters into LOI for Operational Battery Component Manufacturing Facility Lease and Announces Non-Brokered Private Placement Offering

TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSXV: NBM) (OTC: NBMFF), a low-cost, silicon-enhanced battery developer that enables longer-running, rapid-charging batteries for drones, ro... Full story

Yahoo Finance • last month

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at new... Full story

Yahoo Finance • last month

NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims

On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. (NASDAQ:NTRA) asserted against NeoGenomics, Inc.'s (NASDAQ:NEO) v1.1 RaDaR test. Natera s... Full story

Yahoo Finance • last month

Stocks making the biggest moves midday: Petco Health, Celsius, Affirm, Caterpillar & more

Check out the companies making the biggest moves midday: Petco Health & Wellness — The pet store and veterinary services provider surged 22% after raising its full-year adjusted EBITDA guidance. Second-quarter earnings per share topped ana... Full story

Yahoo Finance • last month

NeoGenomics rallies after court win in Natera patent dispute

[Legal rights concept Statue of Lady Justice holding scales of justice] deepblue4you * NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) shares climbed ~20% in the premarket on Friday after the company announced a major vic... Full story

Yahoo Finance • last month

Neo Performance Materials Inc. to Present at the Clean Energy Metals Virtual Investor Conference on August 28th

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF), based in Toronto, focused on advanced industrial materials, today announced that Jonathan Baksh, Executive Vice... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at newac... Full story

Yahoo Finance • 2 months ago

Health care stocks with the largest net increases in hedge fund popularity – Goldman Sachs

[Medical industry stock market graph chart] Rasi Bhadramani Hedge funds increased their overweight positioning in health care (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) despite a 7% decline in the sector during the second quarte... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at newa... Full story

Yahoo Finance • 2 months ago

Legal AI Software Company Evaluation Report 2025 | LexisNexis, Thomson Reuters, and Wolters Kluwer Lead Legal AI with Innovation, Smart Tools, and Strategic Focus

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Legal AI Software - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering. The Legal AI Software Companies Quadrant is a comprehensive industry analysis th... Full story

Yahoo Finance • 2 months ago

Neogenomics stock rating downgraded to Neutral by BTIG on execution concerns

Investing.com - BTIG downgraded Neogenomics (NASDAQ:NEO) from Buy to Neutral on Wednesday, citing concerns about management credibility and product portfolio alignment. The stock, currently trading at $5.25, has declined over 20% in the pa... Full story

Yahoo Finance • 2 months ago

NeoGenomics outlines revised 2025 outlook with 9%-10% revenue growth target amid pharma headwinds and PanTracer launch

Earnings Call Insights: NeoGenomics (NEO) Q2 2025 MANAGEMENT VIEW * CEO Anthony P. Zook stated, "Revenue for Q2 was $181 million, slightly below our second quarter guidance range, though still representing double-digit growth of 10% ye... Full story

Yahoo Finance • 2 months ago

Why Myriad Genetics (MYGN) Shares Are Falling Today

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the healthcare sector became pronounced following a poor sales report from a key competitor. The negative... Full story

Yahoo Finance • 2 months ago

NeoGenomics Non-GAAP EPS of $0.03 beats by $0.01, revenue of $181.3M misses by $1.34M

* NeoGenomics press release [https://seekingalpha.com/pr/20180493-neogenomics-reports-second-quarter-2025-results] (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]): Q2 Non-GAAP EPS of $0.03 beats by $0.01. * Revenue of $181.3M (+10.2... Full story

Yahoo Finance • 2 months ago

NeoGenomics Q2 2025 Earnings Preview

* NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. * The consensus EPS Estimate is $0.02 [https://seekingalpha.com/symbol/NEO/earning... Full story

Yahoo Finance • 2 months ago

VBK's Underlying Holdings Could Mean 12% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 3 months ago

NEOLIFE : Bilan semestriel au 30/06/2025 du contrat de liquidité

Au titre du contrat de liquidité confié par NEOLIFE à TSAF – Tradition Securities And Futures, les moyens suivants figuraient au compte de liquidité en date du 30/06/2025 : 148 729 actions NEOLIFE,41 925,55 €. Il est rappelé que, lors du... Full story